GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (OTCPK:MDVLQ) » Definitions » EPS without NRI

MedAvail Holdings (MedAvail Holdings) EPS without NRI : $-20.47 (TTM As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is MedAvail Holdings EPS without NRI?

MedAvail Holdings's earnings per share without non-recurring items for the three months ended in Jun. 2023 was $-2.56. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was $-20.47.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for MedAvail Holdings's EPS without NRI or its related term are showing as below:

MDVLQ' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -2.1   Med: -2.1   Max: -2.1
Current: -2.1

During the past 4 years, MedAvail Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -2.10% per year. The lowest was -2.10% per year. And the median was -2.10% per year.

MDVLQ's 3-Year EPS without NRI Growth Rate is ranked worse than
66.06% of 492 companies
in the Healthcare Providers & Services industry
Industry Median: 10.45 vs MDVLQ: -2.10

MedAvail Holdings's EPS (Diluted) for the three months ended in Jun. 2023 was $-3.22. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-28.72.

MedAvail Holdings's EPS (Basic) for the three months ended in Jun. 2023 was $-3.22. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $-28.72.


MedAvail Holdings EPS without NRI Historical Data

The historical data trend for MedAvail Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAvail Holdings EPS without NRI Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EPS without NRI
-33.78 -195.09 -67.18 -36.00

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.91 -7.50 -7.00 -3.40 -2.56

Competitive Comparison of MedAvail Holdings's EPS without NRI

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAvail Holdings's PE Ratio without NRI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's PE Ratio without NRI falls into.



MedAvail Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedAvail Holdings  (OTCPK:MDVLQ) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


MedAvail Holdings EPS without NRI Related Terms

Thank you for viewing the detailed overview of MedAvail Holdings's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAvail Holdings (MedAvail Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
Executives
Ramona Seabaugh officer: Chief Financial Officer C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Michael R Kramer director 3910 BRICKWAY BLVD, SANTA ROSA CA 95403
Paul D Johnson director 440 N BARRANCA AVE #3550, COVINA CA 91723
Glen D. Stettin director C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121
Mark Edward Doerr director, officer: Chief Executive Officer C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Abg Wtt-medavail Ltd 10 percent owner 15 QUEENS ROAD CENTRAL, UNIT 3002-3004, 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK, HONG KONG F4 0000000000
Redco Ii Master Fund, L.p. director, 10 percent owner ONE LETTERMAN DRIVE, BLDG D, STE D3-300, SAN FRANCISCO CA 94129
Alyeska Fund Gp, Llc 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, Llc 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investments, Llc 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Anand Parekh 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Master Fund, L.p. 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, L.p. 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Steven Hess officer: Executive Vice President C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Edwin Kilroy director, officer: Chief Executive Officer C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4

MedAvail Holdings (MedAvail Holdings) Headlines

From GuruFocus

Q3 2021 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy

By Stock market mentor Stock market mentor 01-26-2023

Q4 2022 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

MedAvail announces Strategic Restructuring of Business to Focus on Profitability

By Stock market mentor Stock market mentor 01-19-2023

Q3 2022 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2021 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

MedAvail Postpones Reporting of First Quarter 2023 Financial Results

By sperokesalga sperokesalga 05-15-2023